tirzepatide for arthritis 🚨 First-of-its-kind Phase 3b data: treating obesity improves psoriatic outcomes Today, Eli Lilly and Company announced positive topline results from TOGETHER-PsA, the first controlled trial evaluating an incretin therapy used alongside tirzepatide and psoriatic arthritis Frontiers
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8



























